"Ischemia-guided" versus "early invasive" strategies in the management of acute coronary syndrome/non-ST-segment elevation myocardial infarction: The interventionalist's perspective

Journal of the American College of Cardiology

Volumn 41, Issue 4 SUPPL. 4, 2003, Pages S96-S102

  McKay, Raymond G ^a,b  

^a HARTFORD HOSPITAL   (United States)

^b UNIVERSITY OF CONNECTICUT   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DALTEPARIN; DILTIAZEM; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; FIBRINOGEN RECEPTOR ANTAGONIST; HEPARIN; LOW MOLECULAR WEIGHT HEPARIN; NITRATE; TIROFIBAN;

ANGIOCARDIOGRAPHY; CLINICAL TRIAL; CONSERVATIVE TREATMENT; CORONARY ARTERY BYPASS SURGERY; CORONARY STENT; DEATH; DISEASE COURSE; EXERCISE TEST; HEART CATHETERIZATION; HEART INFARCTION; HEART MUSCLE ISCHEMIA; HEART MUSCLE REVASCULARIZATION; HIGH RISK POPULATION; HUMAN; INCIDENCE; MORTALITY; PRIORITY JOURNAL; REVIEW; RISK ASSESSMENT; RISK BENEFIT ANALYSIS; ST SEGMENT ELEVATION;

EID: 0037454025     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0735-1097(02)02688-8     Document Type: Review

References (27)

1. The TIMI IIIB Investigators. Effects of tissue plasminogen activator and a comparison of early invasive and conservative strategies in unstable angina and non-Q-wave myocardial infarction: results of the TIMI IIIB trial. Circulation 1994;89:1545-56.
2. Boden WE, O'Rourke RA, Crawford MH, et al. Outcomes in patients with acute non-Q-wave myocardial infarction randomly assigned to an invasive as compared with a conservative management strategy. N Engl J Med 1998;338:1785-92.
3. Fragmin and Fast Revascularisation During Instability in Coronary Artery Disease Investigators. Invasive compared with non-invasive treatment in unstable coronary artery disease: FRISC II prospective randomised multicentre study. Lancet 1999;354:708-15.
4. Cannon CP, Weintraub WS, Demopoulas LA, et al. Comparison of early invasive and conservative strategies in patients with unstable angina and non-ST-segment elevation myocardial infarction treated with the glycoprotein IIb/IIIa inhibitor tirofiban. N Engl J Med 2001;344:1879-87.
5. Hartzler GO, Rutherford BD, McConahay DR, Johnson WL, Giorgi LV. "High risk" percutaneous transluminal coronary angioplasty. Am J Cardiol 1988;61 Suppl:7G-33G.
6. Myler RK, Shaw RE, Stertyzer SH, et al. Unstable angina and coronary angioplasty. Circulation 1990I;82:I88-95.
7. Adele C, Vaitkus PT, Wells SW, Zehnacker JB. Cost advantages of an ad hoc angioplasty strategy. J Am Coll Cardiol 1998;31:321-5.
8. Antman EM, McCabe CH, Gurfinkel EP, et al. Enoxaparin prevents death and cardiac ischemic events in unstable angina/non-Q-wave myocardial infarction: results of the TIMI IIB trial. Circulation 1999;100:1593-601.
9. Cohen M, Demers C, Gurfinkel EP, et al. The ESSENCE investigators. A comparison of low-molecular-weight heparin with unfractionated heparin for unstable coronary artery disease. N Engl J Med 1997;337:447-52.
10. Antman EM, Cohen M, Radley D, et al. Assessment of the treatment effect of enoxaparin for unstable angina/non-Q-wave myocardial infarction: TIMI 11B-ESSENCE meta-analysis. Circulation 1999;100:1602-8.
11. The EPIC Investigators. Use of a monoclonal antibody directed against the platelet glycoprotein IIb/IIIa receptor in high-risk coronary angioplasty. N Engl J Med 1994;330:956-61.
12. The IMPACT-II Investigators. Randomized placebo-controlled trial of effect of eptifibatide on complications of percutaneous coronary intervention: IMPACT-II. Lancet 1997;349:1422-8.
13. The PURSUIT Trial Investigators. Inhibition of platelet glycoprotein IIb/IIIa with eptifibatide in patients with acute coronary syndromes: platelet glycoprotein IIb/IIIa in unstable angina: receptor suppression using integrelin therapy. N Engl J Med 1998;339:436-43.
14. The PRISM-PLUS Study Investigators. Inhibition of the platelet glycoprotein IIb/IIIa receptor with tirifiban in unstable angina and non-Q-wave myocardial infarction. N Engl J Med 1998;338:1488-97.
15. Harrington RA. Overview of clinical trial of glycoprotein IIb/IIIa inhibitors in acute coronary syndromes. Am Heart J 1999;138:S276-86.
16. Chew DP. A critical appraisal of platelet glycoprotein IIb/IIIa inhibition. J Am Coll Cardiol 2000;36:2028-35.
17. Surruys PW, de Jaegere P, Kiemeneij F, et al. A comparison of balloon-expandable stent implantation with balloon angioplasty in patients with coronary artery disease. N Engl J Med 1994;331:489-95.
18. Lincoff AM, Califf RM, Moliterno DJ, et al. Complementary clinical benefits of coronary artery stenting and blockade of platelet glycoprotein IIb/IIIa receptors. N Engl J Med 1999;341:319-27.
19. Singh M, Holmes DR, Garratt KN, et al. Percutaneous coronary intervention in patients with unstable angina. Indian Heart J 2001;53:155-62.
20. Roberts WC, Jones AA. Quantification of coronary arterial narrowing at necropsy in sudden coronary death. Am J Cardiol 1979;44:39-44.
21. Vlaodaver Z, French R, van Tassel RA, Edwards JE. Correlation of the antemortem coronary angiogram and the posmortem specimen. Circulation 1973;47:162-8.
22. Topol EJ, Nissen SE. Our preoccupation with coronary luminology: the dissociation between clinical and angiographic findings in ischemic heart disease. Circulation 1995;92:2333-42.
23. Little WC, Constantinescu M, Applegate RJ, et al. Can arteriography predict the site of a subsequent myocardial infarction in patients with mild-to-moderate coronary artery disease? Circulation 1988;78:1157-66.
24. Asakura M, Ueda Y, Yamaguchi O, et al, Extensive development of vulnerable plaques as a pan-coronary process in patients with myocardial infarction. J Am Coll Cardiol 2001;37:1284-8.
25. Goldstein JA, Demetriou D, Grine CL, et al. Multiple complex coronary plaques in patients with acute myocardial infarction. N Engl J Med 2000;343:915-22.
26. Brown BG, Zhao XQ, Sacco DE, Albers JJ. Lipid lowering and plaque regression: new insights into prevention of plaque disruption and clinical events in coronary disease. Circulation 1993;87:1781-91.
27. Libby P, Aikawa M. New insights into plaque stabilization by lipid lowering. Drugs 1998;56 Suppl 1:9-13.